To determine whether the synergy observed between aPD1 therapy and UNG depletion in the CT-26 tumor model was CD8+ T cell dependent, the depletion of cytotoxic CD8+ T cells was performed in combination with aPD1 and/or UNG depletion. Here, CD8A is linked to neoplasm.